Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers

Intermittent dosing of glucocorticoid receptor modulators for the treatment of ovarian and other cancers

US Patent 12109272 · Granted Oct 8, 2024

Estimated economic value: $57,270,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of normalizing the neutrophil to lymphocyte ratio in cancer patients with2025
Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2025
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhib2024
Methods of treating antipsychotic-induced weight gain with miricorilant2024
Use of glucocorticoid receptor antagonists in combination with glucocorticoids t2024
Fatty liver disease treatment using glucocorticoid and mineralocorticoid recepto2023
Methods of treating cancer comprising administration of a glucocorticoid recepto2022
Methods for treating Cushing's syndrome2022
Methods of treating cancer comprising administration of a glucocorticoid recepto2022
Use of glucocorticoid receptor antagonists in combination with glucocorticoids t2021
Optimizing mifepristone levels for Cushing's patients2021